{
    "success": true,
    "data": {
        "id": 1089953,
        "msgid": "ppa-content-to-be-reduced-in-medication-1447893297",
        "date": "2001-02-27 00:00:00",
        "title": "PPA content to be reduced in medication",
        "author": null,
        "source": "JP",
        "tags": null,
        "topic": null,
        "summary": "PPA content to be reduced in medication JAKARTA (JP): The Food and Drug Control Agency (BPOM) has set an April 8 deadline for the pharmaceutical industries to lower the content of phenylpropanolamine (PPA), a popular substance used as a decongestant in flu and cough medicines, to a maximum of 15 milligrams per tablet or tablespoon. Many popular cold cure tablets sold over the counter currently contain 25 milligrams of PPA Hydrochloride.",
        "content": "<p>PPA content to be reduced in medication<\/p>\n<p>JAKARTA (JP): The Food and Drug Control Agency (BPOM) has set<br>\nan April 8 deadline for the pharmaceutical industries to lower<br>\nthe content of phenylpropanolamine (PPA), a popular substance<br>\nused as a decongestant in flu and cough medicines, to a maximum<br>\nof 15 milligrams per tablet or tablespoon.<\/p>\n<p>Many popular cold cure tablets sold over the counter currently<br>\ncontain 25 milligrams of PPA Hydrochloride.<\/p>\n<p>Agency chairman Sampurno told journalists after a hearing with<br>\nHouse of Representatives' Commission VII on Population and<br>\nWelfare Affairs that it would also ban advertisements for those<br>\nproducts if the content had not been reduced after April 8.<\/p>\n<p>The Agency's Director of Drugs and Medical Equipment Control<br>\nLucky S. Slamet, the deadline on the reduction of PPA was reached<br>\nfollowing an agreement between the Agency and National Commission<br>\nof Medicine Assessment (Komnas POJ) in December.<\/p>\n<p>They agreed that the content should be reduced in four months.<\/p>\n<p>Prolonged use or an overdose of PPA can cause hemorrhagic<br>\nstroke, high blood pressure and interact adversely with other<br>\nmedication.<\/p>\n<p>The substance can worsen the condition of patients with<br>\ndiabetes, glaucoma or those with kidney or liver problems.<\/p>\n<p>He also said that although there has not been a case in<br>\nIndonesia, warnings on PPA were first raised when the United<br>\nStates Food and Drug Administration highlighted the dangers of<br>\nthe substance.<\/p>\n<p>PPA in the United States is also widely used in diet pills to<br>\nhelp suppress appetite.<\/p>\n<p>Sampurno however here on Monday maintained that consuming the<br>\nsubstance in a proper dosage will avoid negative side effects.<\/p>\n<p>\"Fortunately in Indonesia PPA is only used as a nasal<br>\ndecongestant and cough suppressant and never used to control<br>\nappetite,\" he added.<\/p>\n<p>There are 189 brands of flu and cough medicines containing PPA<br>\nproduced by 79 pharmaceutical firms in the country.<\/p>\n<p>The use of PPA is considered safe if it does not exceed 75<br>\nmilligrams per day for adults, and 37.5 milligrams per day for<br>\nchildren aged between six and 12 years, Sampurno said.<\/p>\n<p>\"Medicines containing PPA are not recommended for children<br>\nunder six and pregnant women, except by doctor's advice,\"<br>\nSampurno asserted.<\/p>\n<p>During the hearing on Monday Sampurno also warned the public<br>\non the existence of fake medicines recently found in a drugstore<br>\nin Mataram, West Nusa Tenggara.<\/p>\n<p>The medicines found were dextracort, dextamin, supertetra in<br>\ncapsules, tetracycline in capsules and chloramphenicol.<\/p>\n<p>\"The producers are now on trial,\" Sampurno claimed without<br>\nelaborating.(hdn)<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/ppa-content-to-be-reduced-in-medication-1447893297",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}